Purchase and successive deliveries of palivizumab
Originaltitel der Bekanntmachung
Poland – Infusion solutions – Zakup i sukcesywne dostawy leku palivizumab UCZKIN.ZP.07.2026.EU
Opportunity Score
Warum diese Bewertung?
Chance
60 / 100
Komplexität
30 / 100
Risikofaktoren
No procurement documents analyzed; eligibility criteria, required documents, and technical specifications are unknown.
Structured data indicates EU funding, but XML notice sets FundingProgramCode to 'no-eu-funds'. This could affect budget...
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Moderate opportunityWichtige Fakten
- Supplies contract
- 1 lot
- Duration until Dec 2026
- Supply of palivizumab (infusion solutions) for RS virus prophylaxis
- Delivery to Warsaw, Poland
Vollständige Zusammenfassung anzeigen
This tender concerns the procurement of palivizumab (infusion solutions) for RS virus prophylaxis for the University Centre for Women's and Newborn Health in Warsaw, Poland. It is an open procedure for a single lot supply contract with award based solely on price. The contract period is from September to December 2026. The estimated value is not disclosed. The submission deadline is 4 August 2026 at 10:00 Warsaw time. EU funding is indicated in structured data but XML notice shows no EU funds. No procurement documents were analyzed.
Risiken
No procurement documents analyzed; eligibility criteria, required documents, and technical specifications are unknown.
Structured data indicates EU funding, but XML notice sets FundingProgramCode to 'no-eu-funds'. This could affect budget...
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Must be able to supply the drug in required quantities
- Delivery to Warsaw, Poland
Administrative
- Electronic submission required via Portal öffnen
Anforderungen können unvollständig sein.
Zuschlagskriterien
Lot 1
Auftraggeber
Name
Uniwersyteckie Centrum Zdrowia Kobiety i Noworodka Warszawskiego Uniwersytetu Medycznego Sp. z o.o.
Ort
Warszawa, POL
Website
Kennung
NIP: 7010389279
Tätigkeit
Health
Lose (1)
LOT-0001
Purchase and successive deliveries of palivizumab
Supply of medicinal product for RS virus prophylaxis for the University Centre for Women's and Newborn Health in Warsaw.
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
C= (cena najtańszej oferty/ cena oferty badanej) x 100
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
Zakup i sukcesywne dostawy leku palivizumab. UCZKIN.ZP.07.2026.EU
Originale TED-Beschreibung
Dostawa produktu leczniczego stosowanego w profilaktyce zakażeń wirusem RS dla Uniwersyteckiego Centrum Zdrowia Kobiety i Noworodka Warszawskiego Uniwersytetu Medycznego Sp. z o.o. w Warszawie.
Vergabedetails
- Veröffentlichungsdatum
- 29 Jun 2026
- Sprachen
- Polish
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 447412-2026
Dokumente (2)
Opportunity Score
Warum diese Bewertung?
Chance
60 / 100
Komplexität
30 / 100
Risikofaktoren
No procurement documents analyzed; eligibility criteria, required documents, and technical specifications are unknown.
Structured data indicates EU funding, but XML notice sets FundingProgramCode to 'no-eu-funds'. This could affect budget...
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications